ESR2 and breast cancer: Furthermore, the ERβ isoform is preferentially lost in some cancers, whereas its introduction slows the growth of breast cancer cells [47], supporting the notion that dysregulation of HR expression either contribute to, or accompany breast tumorigenesis.